Haqq Christopher - SEC Form 4 Insider Trading Screener
18 results - 
- 
- 
- 
- 
- 
- 
- - - - - - | TC | cnt | 1d | 1w | 1m | 6m |
| S | 9 | +1 | +1 | +2 | -28 |
X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Insider Title |
Trade Type |
Share Price |
Shares Traded |
Shares Owned |
Own chg |
Value Traded |
1d ret |
1w ret |
1m ret |
6m ret |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2018-05-15 | ATRA | Haqq Christopher | EVP, R, D, Chief Scientific Of | S - Sale+OE | $45.30 | -25,775 | 352,130 | -7% | -$1,167,480 | |||||
2018-03-26 | ATRA | Haqq Christopher | EVP, R, D, Chief Scientific Of | S - Sale | $39.79 | -18,327 | 352,905 | -5% | -$729,265 | ||||||
| D | 2017-11-15 | ATRA | Haqq Christopher | EVP, R, D, Chief Scientific Of | S - Sale+OE | $13.36 | -1,604 | 362,530 | 0% | -$21,429 | |||||
2017-10-16 | ATRA | Haqq Christopher | EVP, R, D, Chief Scientific Of | S - Sale | $14.35 | -6,000 | 363,305 | -2% | -$86,100 | ||||||
2017-09-15 | ATRA | Haqq Christopher | EVP, R, D, Chief Scientific Of | S - Sale | $15.30 | -6,000 | 369,305 | -2% | -$91,800 | ||||||
| D | 2017-08-15 | ATRA | Haqq Christopher | EVP, R, D, Chief Scientific Of | S - Sale+OE | $14.75 | -7,604 | 375,305 | -2% | -$112,159 | |||||
2017-07-17 | ATRA | Haqq Christopher | EVP, R, D, Chief Scientific Of | S - Sale | $14.92 | -6,000 | 382,080 | -2% | -$89,520 | ||||||
2017-06-15 | ATRA | Haqq Christopher | EVP, R, D, Chief Scientific Of | S - Sale | $12.65 | -6,000 | 388,080 | -2% | -$75,900 | ||||||
| D | 2017-05-15 | ATRA | Haqq Christopher | EVP, R, D, Chief Scientific Of | S - Sale+OE | $14.99 | -7,604 | 394,080 | -2% | -$113,984 | |||||
2017-04-17 | ATRA | Haqq Christopher | EVP, R, D, Chief Scientific Of | S - Sale | $17.28 | -6,000 | 400,855 | -1% | -$103,680 | +2 | -5 | ||||
2017-03-15 | ATRA | Haqq Christopher | EVP, R, D, Chief Scientific Of | S - Sale | $19.60 | -6,000 | 406,855 | -1% | -$117,600 | +6 | +5 | -13 | |||
| D | 2017-02-15 | ATRA | Haqq Christopher | EVP, R, D, Chief Scientific Of | S - Sale+OE | $15.49 | -7,604 | 412,855 | -2% | -$117,786 | 0 | -5 | +28 | ||
2017-02-09 | ATRA | Haqq Christopher | EVP, R, D, Chief Scientific Of | S - Sale | $15.46 | -13,975 | 419,630 | -3% | -$216,054 | +1 | +3 | +48 | |||
2017-01-17 | ATRA | Haqq Christopher | EVP, R, D, Chief Scientific Of | S - Sale | $14.27 | -6,000 | 384,105 | -2% | -$85,620 | -4 | -7 | +10 | |||
2016-12-15 | ATRA | Haqq Christopher | Chief Medical Officer | S - Sale | $15.40 | -6,000 | 390,105 | -2% | -$92,400 | +1 | -3 | -12 | |||
2016-11-21 | ATRA | Haqq Christopher | Chief Medical Officer | S - Sale | $17.85 | -7,068 | 396,105 | -2% | -$126,164 | +6 | +12 | -15 | |||
| D | 2016-11-15 | ATRA | Haqq Christopher | Chief Medical Officer | S - Sale+OE | $19.95 | -1,604 | 403,173 | 0% | -$32,000 | -2 | +6 | -12 | ||
| D | 2016-08-15 | ATRA | Haqq Christopher | Chief Medical Officer | S - Sale+OE | $22.32 | -1,346 | 313,948 | 0% | -$30,041 | +2 | 0 | -14 | -28 |
Real-time CSV? Options? Alerts? Contact us!
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |